News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 289–324
- Matches
- 4025
- Sources here
- 21
- Companies here
- 27
Active search
4025 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research
Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …
Martin Marietta reports increased revenue for Q2
Martin Marietta Materials Inc. announced a 21 percent increase in revenue for the second quarter of 2026, reaching $1.95 billion, despite a 12 percent decrease in net income from continuing operations to $256 million. The company reported record aggregate shipments of 61.6 million tons, …
What's Backing Abbott's Established Pharmaceuticals Division Growth
Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …
Sharemaestro market context Price above Trend Line 52 weeks -1.0% · Next-week setup positive 57.3%TTEC Government Solutions Awarded $21 Million Contract to Modernize IRS Contact Center Infrastructure
TTEC Government Solutions, a subsidiary of TTEC, has been awarded a one-year, $21 million contract by the IRS to modernize its contact center infrastructure. The contract positions TTEC as the prime contractor for operating, sustaining, and enhancing the IRS's IT infrastructure, which supports over …
Understanding Momentum Shifts in (TTMI)
This article analyzes Ttm Technologies Inc. (TTMI), highlighting a neutral near and mid-term outlook that could moderate a long-term positive bias. It identifies a mid-channel oscillation pattern and an exceptional 96.4:1 risk-reward setup targeting a 27.6% gain against 0.3% risk. The piece also details …
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …
Here's What We Like About Sprott's (TSE:SII) Upcoming Dividend
Sprott Inc. (TSE:SII) is set to trade ex-dividend soon, with a dividend payment of US$0.40 per share scheduled for September 1st. The company boasts a comfortable payout ratio of 39% of its profit, indicating a sustainable dividend, and has shown strong earnings growth of …
Sharemaestro market context Price below Trend Line 52 weeks +81.1%Q3 EPS Estimates for Shattuck Labs Raised by HC Wainwright
HC Wainwright has raised its Q3 2026 EPS estimate for Shattuck Labs (NASDAQ:STTK) to a loss of $0.09 per share, an improvement from the previous estimate of a $0.21 loss. The firm maintained a "Buy" rating and a $14 price target, while the overall …
The Hackett Group (NASDAQ:HCKT) Cut to "Strong Sell" at Zacks Research
Zacks Research has downgraded The Hackett Group (NASDAQ:HCKT) to a "strong sell" rating, contributing to a consensus "reduce" rating among analysts with a target price of $16.50. Despite meeting EPS expectations and slightly exceeding revenue estimates in its latest quarter, the stock has opened …
Cantor Fitzgerald Downgrades Better Home & Finance to Neutral From Overweight, Adjusts PT to $16 From $32
Cantor Fitzgerald has downgraded Better Home & Finance (BETR) to Neutral from Overweight and significantly reduced its price target from $32 to $16. This adjustment reflects a more cautious outlook on the company's prospects. The article also provides recent news and company profile information …
Cabaletta Bio reports Q2 2026 net loss of $51.0M; cash position $225.1M supports operations into mid-2027
Cabaletta Bio reported a net loss of $51.0 million for Q2 2026, with operating expenses of $52.0 million. The company's cash position of $225.1 million, as of June 30, 2026, is expected to fund operations into mid-2027. Cabaletta also highlighted progress in its RESET …
Cabaletta Bio Reports $51.0 Million Second-Quarter Net Loss
Cabaletta Bio reported a net loss of $51.0 million, or $0.34 per share, for the second quarter of 2026, with research and development expenses at $44.4 million. The company ended the quarter with $225.1 million in cash, expected to fund operations into mid-2027, and …
Cabaletta Bio, Inc. 2Q 2026: Net loss $(51.0)M, EPS $(0.34) — 10-Q Summary
Cabaletta Bio, Inc. reported a net loss of $(51.0)M for the second quarter of 2026, with a diluted loss per share of $(0.34). The company remains pre-revenue, focusing on advancing multiple RESET™ clinical programs and scaling manufacturing. They have achieved clinical progress with positive …
Cabaletta Bio (CABA) lifts cash to $225M while advancing rese-cel toward BLA
Cabaletta Bio (CABA) announced its second quarter 2026 financial results, reporting a net loss of $51.0 million but increasing its cash, cash equivalents, and short-term investments to $225.1 million, which is expected to fund operations into mid-2027. The company is advancing its lead CAR …
Form 8K Cabaletta Bio Inc For: 13 August By Investing.com
This article reports on Cabaletta Bio Inc.'s Form 8K filing for August 13th, as published by Investing.com. It is a brief announcement without further details within the provided text. The article is primarily a stub, directing readers to a comments section.
Natural Grocers by Vitamin Cottage (NYSE:NGVC) Could Be A Buy For Its Upcoming Dividend
Natural Grocers by Vitamin Cottage (NYSE:NGVC) is about to trade ex-dividend, offering a payment of US$0.15 per share, totaling US$0.60 annually, which represents a 2.2% trailing yield. The company's dividend appears sustainable, with a modest payout ratio of 28% of profits and 59% of …
ScottsMiracle-Gro Brings America250’s “Our American Story” to ScottsMiracle-Gro Field
Scotts Miracle-Gro Company (The) Ohioans and Columbus Crew fans are invited to discover the national initiative and record their stories for historic preservation COLUMBUS, Ohio, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn …